Methyl Methacrylate MMA Monomer

Methyl Methacrylate MMA Monomer Market Outlook

The global Methyl Methacrylate (MMA) monomer market is projected to reach approximately USD 5.3 billion by the year 2035, growing at a robust CAGR of around 7.2% during the forecast period from 2025 to 2035. This growth trajectory is primarily driven by the increasing demand for MMA in various applications such as dentistry, orthopedic surgeries, and trauma surgeries. The expanding healthcare sector, coupled with technological advancements in surgical procedures, is anticipated to further propel the market. Additionally, the rise in geriatric populations requiring orthopedic surgeries and dental care is catalyzing this growth. Furthermore, the versatility of MMA in producing high-strength bone cements and its effective bonding properties make it a preferred choice in the medical field, thereby enhancing its market footprint. The increasing prevalence of bone-related disorders and the growing awareness of minimally invasive surgical techniques are expected to boost this market significantly.

Growth Factor of the Market

One of the primary growth factors for the Methyl Methacrylate (MMA) monomer market is the increasing incidence of orthopedic and dental surgeries. As the global population ages, the need for joint replacements and dental procedures is rising, leading to a higher demand for MMA-based products. Moreover, advancements in surgical technologies have led to more efficient and effective procedures that utilize Methyl Methacrylate, thereby increasing its adoption across healthcare facilities. The growth of the cosmetic surgery sector is also contributing to the market, as MMA is increasingly used in aesthetic procedures. Additionally, the rise in sports-related injuries is resulting in more trauma surgeries, further driving the requirement for MMA monomers in bone cement formulations. The expanding range of applications of MMA in various surgical disciplines adds to the market's robustness and future potential.

Key Highlights of the Market

• Projected global market size of USD 5.3 billion by 2035, with a CAGR of 7.2%.
• Increased demand in orthopedic and dental applications due to an aging population.
• Expansion of the healthcare sector and advancements in surgical technologies.
• Significant growth driven by the rise in sports-related injuries and trauma surgeries.
• Versatile usage of MMA in various surgical disciplines enhances market prospects.

By Product Type

Orthopedic Bone Cement:

The orthopedic bone cement segment is a significant contributor to the Methyl Methacrylate (MMA) monomer market, as it is widely utilized for securing implants during joint replacement surgeries. This type of bone cement is known for its excellent mechanical properties, ensuring stability and longevity of the implants. It is particularly important in procedures such as total hip and knee arthroplasties, where reliable fixation is critical. The trend toward minimally invasive surgical techniques is also benefitting this segment as orthopedic bone cements allow for less trauma to surrounding tissues, promoting quicker recovery times for patients. Continued research and development efforts aimed at enhancing the performance of MMA-based orthopedic cements further solidify their market presence.

Dental Bone Cement:

The dental bone cement segment is experiencing considerable growth due to the rising prevalence of dental procedures, including implants and prosthodontics. Methyl Methacrylate is widely used as a bonding agent in dental applications, providing excellent adhesion and biocompatibility. The increasing focus on cosmetic dentistry and the demand for effective dental restorative materials are further driving the need for MMA-based dental cements. Additionally, advancements in dental technologies and materials are enhancing the performance and application scope of dental bone cements, making them an essential component in modern dentistry.

Craniofacial Bone Cement:

Craniofacial bone cement is another critical segment within the MMA monomer market, finding its applications in reconstructive and cosmetic surgeries. The use of MMA in craniofacial applications is primarily due to its ability to provide strong fixation and support for cranial implants. The growing demand for craniofacial surgeries, especially among individuals with congenital deformities or trauma injuries, is contributing to the market's growth. Innovations aimed at improving the properties of craniofacial bone cement, such as bioactivity and osteoconductivity, are expected to further enhance the segment's performance.

Spinal Bone Cement:

The spinal bone cement segment is gaining traction as the prevalence of spinal surgeries, such as vertebroplasty and kyphoplasty, increases. Methyl Methacrylate is prominently used in these procedures to stabilize fractured vertebrae and provide structural support during the healing process. The growing aging population and the rise in conditions such as osteoporosis are driving the demand for spinal interventions, thereby boosting the usage of spinal bone cements. Furthermore, ongoing research aimed at enhancing the biomechanical properties of MMA for spinal applications is anticipated to solidify this segment's market position.

Others:

The 'Others' segment encompasses various niche applications of Methyl Methacrylate, including its use in surgical adhesives and other types of medical cements. Although this segment constitutes a smaller share of the overall market, it is growing due to the increasing versatility of MMA in different medical applications. The ongoing developments aimed at enhancing the properties of MMA for specialized applications are expected to drive growth in this segment. As the medical field evolves, the usage of MMA in diverse applications continues to expand, contributing to the overall market dynamics.

By Application

Dentistry:

Methyl Methacrylate plays a pivotal role in the dental sector, particularly in the bonding of crowns, bridges, and dental implants. Its excellent adhesive properties and biocompatibility make it a preferred choice among dental professionals. The growing emphasis on aesthetic procedures and dental restorations is driving the demand for MMA-based products. Additionally, advancements in dental materials and techniques are enabling more effective and efficient use of MMA in various dental applications, further propelling this segment's growth.

Orthopedic Surgery:

In orthopedic surgery, Methyl Methacrylate is primarily used for implant fixation, making it a crucial component in joint replacement procedures. The increase in the number of joint surgeries, driven by the aging population, is significantly enhancing the demand for MMA-based orthopedic cements. Moreover, the development of new formulations and techniques aimed at improving the performance and reducing the complications associated with MMA use is fostering growth in this segment. The emphasis on minimally invasive procedures is also steering the orthopedic surgery market towards more efficient MMA applications.

Trauma Surgery:

Methyl Methacrylate is commonly used in trauma surgeries for stabilizing fractures and enhancing bone healing. The rise in road traffic accidents and sports injuries is contributing to the growing demand for MMA in trauma applications. The ability of MMA to provide strong fixation for fractured bones is a significant advantage, making it an essential component in trauma surgical procedures. As the global awareness of sports safety and injury prevention increases, the need for effective trauma solutions, including MMA applications, is expected to rise further.

Spinal Surgery:

In spinal surgery, Methyl Methacrylate is utilized in procedures like vertebroplasty and kyphoplasty to stabilize collapsed vertebrae. The growing prevalence of spinal disorders and the aging population are driving the demand for MMA in spinal applications. The effectiveness of MMA in providing stabilizing support during spinal surgeries enhances its adoption among healthcare providers. Moreover, ongoing innovations aimed at improving the properties of MMA for spinal applications are anticipated to fuel growth in this segment.

Others:

The 'Others' application segment encompasses various medical fields where Methyl Methacrylate is employed beyond the primary surgical applications. This includes its use in surgical adhesives and other specialty applications that may not fall into the traditional categories. Although smaller in terms of market share, this segment is expected to grow as new applications for MMA are discovered and developed. Continued research and development efforts will likely lead to an expansion of MMA's role in diverse surgical and medical applications, thus contributing to the overall market growth.

By Distribution Channel

Hospitals:

The hospital distribution channel is the primary market for Methyl Methacrylate, as it is widely utilized in surgical settings for orthopedic, dental, and trauma surgeries. The availability of advanced surgical facilities and skilled personnel in hospitals drives the demand for MMA products. Hospitals often stock a variety of MMA-based cements to ensure they can cater to various surgical needs. The increasing number of surgeries performed in hospitals, driven by the rising incidence of orthopedic and dental conditions, continues to bolster this distribution channel.

Specialty Clinics:

Specialty clinics are an essential distribution channel for Methyl Methacrylate, particularly in dentistry and orthopedic surgery. These clinics focus on specific medical fields, which allows for a more tailored approach to patient care and treatment. The demand for MMA in specialty clinics is growing as patients seek targeted treatments and advanced solutions for their conditions. Moreover, the increasing number of specialty clinics and the emphasis on personalized medicine are expected to enhance the market potential for MMA in this segment.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are emerging as a vital distribution channel for Methyl Methacrylate, particularly for outpatient procedures. These centers offer the advantage of providing surgical care without the need for hospital admission, making them an attractive option for patients. The growing trend towards outpatient surgeries, especially in orthopedic and dental fields, is driving the demand for MMA-based products in ASCs. As the healthcare industry shifts towards more cost-effective solutions, the role of ASCs in the Methyl Methacrylate market is expected to expand.

Online Stores:

Online stores are becoming an increasingly popular distribution channel for Methyl Methacrylate as the medical supply market embraces digital transformation. The convenience of ordering medical supplies and the ability to compare prices and products online are appealing to healthcare providers. The growing trend towards telemedicine and remote healthcare services is also encouraging the use of online platforms for purchasing MMA products. As e-commerce continues to evolve, its impact on the distribution of Methyl Methacrylate is anticipated to grow.

Others:

The 'Others' distribution channel includes various alternative sources for obtaining Methyl Methacrylate beyond the traditional channels. This may include direct sales from manufacturers or specialized suppliers catering to niche markets. While smaller in scale, this segment is important as it reflects the diverse channels available to healthcare providers for sourcing MMA products. The continued evolution of distribution methods and the growing focus on efficiency in supply chains are expected to influence the dynamics of this market segment.

By Ingredient Type

Acrylic Resins:

Acrylic resins are a significant component of Methyl Methacrylate formulations, contributing to their strength and durability. These resins are essential for creating high-performance bone cements that can withstand the stresses exerted in surgical applications. The demand for acrylic resins is expected to grow in line with the increased adoption of MMA in various medical procedures, particularly in orthopedic and dental applications. Ongoing innovations aimed at enhancing the properties of acrylic resins, such as improved flexibility and adhesion, are anticipated to drive this segment further.

Monomers:

Monomers are crucial in the formulation of Methyl Methacrylate products, serving as the building blocks for polymerization. The rising demand for MMA in various applications is expected to boost the market for monomers significantly. As the healthcare sector continues to evolve, the focus on developing high-quality and effective monomer-based products will enhance their relevance in the market. Furthermore, the advancements in polymer technology are likely to expand the range of applications for MMA monomers, driving market growth.

Initiators:

Initiators play a vital role in the polymerization of Methyl Methacrylate, facilitating the curing process of the cements. The demand for effective initiators is increasing as more healthcare providers seek reliable and rapid-setting solutions for surgical applications. Innovations in initiator technologies, aimed at improving curing times and overall performance, are expected to enhance their market potential. As the MMA market grows, the significance of initiators in ensuring the efficacy and reliability of MMA products will continue to rise.

Inhibitors:

Inhibitors are essential in controlling the polymerization of Methyl Methacrylate, ensuring that the materials remain workable until they are ready for use in surgical applications. The market for inhibitors is expected to grow as the demand for MMA products increases. The focus on quality and performance in MMA formulations is driving the need for effective inhibitors that can enhance the shelf life and usability of MMA-based cements. Continuous advancements in inhibitor technologies will further solidify their relevance in the Methyl Methacrylate market.

Others:

The 'Others' ingredient type segment includes various components used in the formulation of Methyl Methacrylate that do not fall into the conventional categories. This may encompass additives that enhance specific properties of MMA products, such as colorants or fillers, which can improve the aesthetic appearance or structural integrity of the cements. Although smaller in market share, this segment reflects the diversity of formulations available in the MMA space. As the industry continues to innovate, the exploration of alternative ingredient types may contribute to the overall growth of the market.

By Region

The North American region is poised to dominate the Methyl Methacrylate (MMA) monomer market, accounting for approximately 45% of the global market share by 2035. The growth in this region can be attributed to the advanced healthcare infrastructure, increasing prevalence of orthopedic and dental procedures, and the rising demand for minimally invasive surgical techniques. The United States, in particular, is at the forefront of adopting new surgical technologies that utilize MMA, thus contributing significantly to the market's expansion. The region is expected to maintain a CAGR of around 7.5% during the forecast period, reflecting the continued investment in healthcare innovation and the growing demand for surgical solutions.

In Europe, the Methyl Methacrylate market is anticipated to grow steadily, capturing around 25% of the global share by 2035. The growth in this region is driven by the aging population and the increasing focus on advanced medical treatments. Countries such as Germany, France, and the UK are leading the charge in adopting MMA products for various surgical applications. The emphasis on research and development in healthcare technologies in Europe is expected to further bolster the utilization of MMA in medical procedures. Additionally, the introduction of new products and formulations aimed at enhancing the performance of MMA in surgical applications will likely accelerate market growth in the European region.

Opportunities

The Methyl Methacrylate (MMA) monomer market is witnessing numerous opportunities, particularly due to the growing demand for advanced surgical techniques and materials. As healthcare systems worldwide continue to evolve, there is an increasing need for reliable and effective surgical solutions that can enhance patient outcomes. The rise in minimally invasive surgical procedures is one such opportunity that the MMA market can leverage. By offering cements and adhesives that cater to the specific needs of these procedures, manufacturers can tap into a segment that is rapidly gaining traction. Furthermore, with an increasing focus on research and development, companies can explore innovative formulations that improve the properties of MMA products, making them more attractive to healthcare providers and patients alike.

Additionally, the expansion of the cosmetic surgery market presents lucrative opportunities for Methyl Methacrylate manufacturers. As more individuals seek aesthetic enhancements, the demand for biocompatible materials that can be used in cosmetic procedures is on the rise. The versatility of MMA allows it to be adapted for various applications, including dermal fillers and implants, thus opening up new markets for manufacturers. Moreover, the increasing awareness and adoption of 3D printing technologies in the medical field hold promise for the MMA market, as customized solutions can be developed for specific surgical needs. This potential for innovation and adaptation will likely lead to sustained growth and expansion opportunities in the Methyl Methacrylate market.

Threats

Despite the promising growth trajectory of the Methyl Methacrylate (MMA) monomer market, several threats could impact its expansion. One of the primary concerns is the potential for regulatory challenges as governments and health organizations continue to tighten regulations surrounding medical materials. Compliance with these regulations can be time-consuming and costly for manufacturers, which may hinder market entry for new players or challenge existing companies. Furthermore, the rapid pace of technological advancements in the medical field means that companies must continually adapt to remain competitive. Failing to innovate and keep up with the latest developments can result in a loss of market share or relevance, as healthcare providers increasingly look for the best solutions for their patients.

Another significant threat facing the MMA market is the competition from alternative materials and bonding agents. As new technologies emerge and other materials are developed, they may offer comparable or superior properties to MMA-based products, thus attracting healthcare providers. For instance, bioactive or biodegradable materials are increasingly being explored for use in surgical applications, presenting potential competition for Methyl Methacrylate. Additionally, economic factors such as fluctuations in raw material prices and supply chain disruptions could impact the production and availability of MMA, affecting market stability. Addressing these threats will be crucial for the continued growth and sustainability of the Methyl Methacrylate monomer market.

Competitor Outlook

• Evonik Industries AG
• BASF SE
• Lucite International
• Huntsman Corporation
• Mitsubishi Chemical Corporation
• Alpha Calcit
• Reichhold LLC
• 3M Company
• Scapa Group PLC
• Wacker Chemie AG
• Innocent Technologies
• Saint-Gobain S.A.
• Dow Chemical Company
• Rohm and Haas Company
• Solvay S.A.

The competitive landscape of the Methyl Methacrylate (MMA) monomer market is characterized by the presence of several key players that dominate the industry. Leading companies such as Evonik Industries AG and BASF SE have established themselves as significant contributors to the market, driven by their extensive product portfolios and commitment to innovation. These companies invest heavily in research and development to enhance the performance and application scope of their MMA products, ensuring they remain competitive in the rapidly evolving healthcare landscape. The presence of large multinational corporations with vast distribution networks also allows them to reach a wide customer base, thereby solidifying their market positions.

Furthermore, companies like Mitsubishi Chemical Corporation and Huntsman Corporation are making strides in the MMA market by focusing on sustainability and eco-friendly practices. As the demand for environmentally responsible products increases, these companies are positioning themselves as leaders in the development of MMA formulations that minimize environmental impact. The competitive landscape is also witnessing the entry of smaller players and startups that bring innovative solutions to the market. These companies often focus on niche applications or specific regions, providing targeted products that cater to the unique needs of certain customer segments. This dynamic creates a vibrant competitive environment where established players must continuously innovate to maintain their market share.

Some of the key players, such as 3M Company and Wacker Chemie AG, are known for their strong emphasis on quality and regulatory compliance, ensuring that their MMA products meet stringent industry standards. This focus on quality is essential in the healthcare sector, where the safety and efficacy of materials used in surgical procedures are paramount. Additionally, partnerships and collaborations among industry players are becoming increasingly common as companies seek to combine resources, technologies, and expertise to enhance their offerings. This trend is expected to foster further innovation and drive growth in the Methyl Methacrylate market, as companies work together to develop cutting-edge solutions that address the evolving needs of the healthcare industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 3M Company
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Solvay S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Alpha Calcit
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Reichhold LLC
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Scapa Group PLC
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Wacker Chemie AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Saint-Gobain S.A.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Dow Chemical Company
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Evonik Industries AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Huntsman Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Lucite International
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Innocent Technologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Rohm and Haas Company
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Mitsubishi Chemical Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Methyl Methacrylate MMA Monomer Market, By Application
    • 6.1.1 Dentistry
    • 6.1.2 Orthopedic Surgery
    • 6.1.3 Trauma Surgery
    • 6.1.4 Spinal Surgery
    • 6.1.5 Others
  • 6.2 Methyl Methacrylate MMA Monomer Market, By Product Type
    • 6.2.1 Orthopedic Bone Cement
    • 6.2.2 Dental Bone Cement
    • 6.2.3 Craniofacial Bone Cement
    • 6.2.4 Spinal Bone Cement
    • 6.2.5 Others
  • 6.3 Methyl Methacrylate MMA Monomer Market, By Ingredient Type
    • 6.3.1 Acrylic Resins
    • 6.3.2 Monomers
    • 6.3.3 Initiators
    • 6.3.4 Inhibitors
    • 6.3.5 Others
  • 6.4 Methyl Methacrylate MMA Monomer Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Methyl Methacrylate MMA Monomer Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Methyl Methacrylate MMA Monomer market is categorized based on

By Product Type

• Orthopedic Bone Cement
• Dental Bone Cement
• Craniofacial Bone Cement
• Spinal Bone Cement
• Others

By Application

• Dentistry
• Orthopedic Surgery
• Trauma Surgery
• Spinal Surgery
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Stores
• Others

By Ingredient Type

• Acrylic Resins
• Monomers
• Initiators
• Inhibitors
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Evonik Industries AG
• BASF SE
• Lucite International
• Huntsman Corporation
• Mitsubishi Chemical Corporation
• Alpha Calcit
• Reichhold LLC
• 3M Company
• Scapa Group PLC
• Wacker Chemie AG
• Innocent Technologies
• Saint-Gobain S.A.
• Dow Chemical Company
• Rohm and Haas Company
• Solvay S.A.